United Therapeutics Corp. (UTHR)
568.43
+2.56
(+0.45%)
USD |
NASDAQ |
May 22, 16:00
568.53
+0.10
(+0.02%)
After-Hours: 20:00
United Therapeutics EPS Diluted (Quarterly) : 5.824 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | -0.0539 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Insmed, Inc. | -0.7591 |
| Amgen, Inc. | 3.344 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 274.90M |
| Revenue (Quarterly) | 781.50M |
| Total Expenses (Quarterly) | 506.60M |
| Enterprise Value | 21.97B |
| Gross Profit Margin (Quarterly) | 82.93% |
| Profit Margin (Quarterly) | 35.18% |
| Earnings Yield | 4.77% |
| Operating Earnings Yield | 5.40% |
| Normalized Earnings Yield | 4.539 |